Sokol J, Guman T, Chudej J, Hlebaskova M, et al. Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma. Ann Hematol 2022;101:81-89.
PMID: 34550463